Speeding innovation for industry
Micro and nanotechnology for healthcare
CardioRenal has set the ambitious goal of revolutionizing the monitoring of patients suffering from severe heart failure with a remote system developed in partnership with Leti, a CEA Tech institute. Heart failure patients are often hospitalized for tests after a congestive episode; these hospital stays could be avoided if the patients' treatment protocols could be more accurately adjusted to their condition. For example, doctors often prescribe drug dosages that are too low due to their concerns about side effects like liver damage and potassium deficiency. CardioRenal will give doctors a safety net that will allow them to more effectively prescribe treatments.
Patients will soon be able analyze significant biological markets like hemoglobin, creatinine, and potassium, simply by placing a drop of blood on the miniaturized testing device. Leti's contributions to the new product included know-how in microfluidics, electrochemistry, and optics—all needed to prepare the blood sample and carry it through micrometric channels to reliable, high-performance optical (hemoglobin) and electrochemical (creatinine and potassium) sensors, also supplied by Leti.
The partners recently set up a joint lab to pursue their work.
CEA is a French government-funded technological research organisation in four main areas: low-carbon energies, defense and security, information technologies and health technologies. A prominent player in the European Research Area, it is involved in setting up collaborative projects with many partners around the world.